Xponance, Inc. Catalent, Inc. Transaction History

Xponance, Inc.

$10.2 Billion
Q3 2024

A detailed history of Xponance, Inc. transactions in Catalent, Inc. stock. As of the latest transaction made, Xponance, Inc. holds 24,596 shares of CTLT stock, worth $1.49 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

24,596

Previous 24,156 1.82%

Holding current value

$1.49 Million

Previous $1.36 Million 9.65%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$56.16 - $60.96 $24,710 - $26,822	440 Added 1.82%	24,596 $1.49 Million
Q2 2024 Aug 14, 2024	SELL	$53.58 - $57.02 $18,860 - $20,071	-352 Reduced 1.44%	24,156 $1.36 Million
Q1 2024 May 13, 2024	BUY	$42.56 - $59.82 $52,902 - $74,356	1,243 Added 5.34%	24,508 $1.38 Million
Q4 2023 Jan 31, 2024	SELL	$32.18 - $46.57 $99,210 - $143,575	-3,083 Reduced 11.7%	23,265 $1.05 Million
Q3 2023 Oct 23, 2023	SELL	$44.2 - $50.2 $8,177 - $9,287	-185 Reduced 0.7%	26,348 $1.2 Million
Q2 2023 Jul 13, 2023	SELL	$31.86 - $67.26 $109,534 - $231,239	-3,438 Reduced 11.47%	26,533 $1.15 Million
Q1 2023 Apr 17, 2023	SELL	$45.44 - $74.26 $53,937 - $88,146	-1,187 Reduced 3.81%	29,971 $1.97 Million
Q4 2022 Jan 23, 2023	BUY	$41.39 - $81.0 $304,920 - $596,727	7,367 Added 30.97%	31,158 $0
Q3 2022 Oct 24, 2022	BUY	$72.36 - $113.1 $206,515 - $322,787	2,854 Added 13.63%	23,791 $1.72 Million
Q2 2022 Aug 02, 2022	BUY	$87.2 - $114.05 $457,189 - $597,964	5,243 Added 33.41%	20,937 $2.25 Million
Q1 2022 Apr 20, 2022	BUY	$94.19 - $124.49 $40,878 - $54,028	434 Added 2.84%	15,694 $1.74 Million
Q4 2021 Jan 31, 2022	BUY	$119.57 - $139.07 $316,501 - $368,118	2,647 Added 20.99%	15,260 $1.95 Million
Q3 2021 Nov 05, 2021	SELL	$109.17 - $142.35 $87,445 - $114,022	-801 Reduced 5.97%	12,613 $1.68 Million
Q2 2021 Aug 12, 2021	BUY	$100.34 - $115.69 $607,157 - $700,040	6,051 Added 82.18%	13,414 $1.45 Million
Q1 2021 May 10, 2021	BUY	$101.51 - $125.27 $17,155 - $21,170	169 Added 2.35%	7,363 $775,000
Q4 2020 Feb 11, 2021	BUY	$85.88 - $105.36 $38,817 - $47,622	452 Added 6.7%	7,194 $749,000
Q3 2020 Oct 26, 2020	SELL	$72.74 - $92.5 $587,957 - $747,677	-8,083 Reduced 54.52%	6,742 $578,000
Q2 2020 Aug 14, 2020	BUY	$48.02 - $79.04 $711,896 - $1.17 Million	14,825 New	14,825 $1.09 Million

Others Institutions Holding CTLT

# of Institutions

514

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account